Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8P88

X-ray structure of cardiotoxic light chain H3 in complex to neutralizing nanobody C4

Summary for 8P88
Entry DOI10.2210/pdb8p88/pdb
DescriptorLight Chain H3, Nanobody C4, CHLORIDE ION, ... (5 entities in total)
Functional Keywordsal amyloidosis, toxicity, neutralization, nanobody, immune system
Biological sourceHomo sapiens
More
Total number of polymer chains2
Total formula weight35785.79
Authors
Broggini, L.,Ricagno, S. (deposition date: 2023-05-31, release date: 2024-01-31, Last modification date: 2024-11-13)
Primary citationBroggini, L.,Barzago, M.M.,Speranzini, V.,Schulte, T.,Sonzini, F.,Giono, M.,Romeo, M.,Milani, P.,Caminito, S.,Mazzini, G.,Rognoni, P.,Merlini, G.,Pappone, C.,Anastasia, L.,Nuvolone, M.,Palladini, G.,Diomede, L.,Ricagno, S.
Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation.
J.Mol.Biol., 435:168320-168320, 2023
Cited by
PubMed Abstract: Light chain amyloidosis (AL) is a systemic disease where fibrillar deposition of misfolded immunoglobulin light chains (LCs) severely affects organ function and results in poor prognosis for patients, especially when heart involvement is severe. Particularly relevant in this context is the cardiotoxicity exerted by still uncharacterized soluble LC species. Here, with the final goal of identifying alternative therapeutic strategies to tackle AL amyloidosis, we produced five llama-derived nanobodies (Nbs) specific against H3, a well-characterized amyloidogenic and cardiotoxic LC from an AL patient with severe cardiac involvement. We found that Nbs are specific and potent agents capable of abolishing H3 soluble toxicity in C. elegans in vivo model. Structural characterization of H3-Nb complexes revealed that the protective effect of Nbs is related to their ability to bind to the H3 V domain and stabilise an unexpected partially open LC dimer in which the two V domains no longer interact with each other. Thus, while identifying potent inhibitors of LC soluble toxicity, we also describe the first non-native structure of an amyloidogenic LC that may represent a crucial step in toxicity and aggregation mechanisms.
PubMed: 37865287
DOI: 10.1016/j.jmb.2023.168320
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.022 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon